Marketwired .

Subscribe to Marketwired .: eMailAlertsEmail Alerts
Get Marketwired .: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

Top Stories by Marketwired .

VIENNA, VA -- (MARKET WIRE) -- 04/15/05 -- H-Quotient, Inc., (OTC: HQNT) announced that the NASD, following its normal procedures, has established April 25, 2005, as the ex-dividend date for the dividend being distributed on April 22, 2005. Stockholders who purchased H-Quotient shares on or before February 22, 2005, will receive the dividend from Continental Stock Transfer on April 22, 2005. However, if they sell the H-Quotient shares before April 22, 2005, the dividend will be relinquished under "due bills" to stockholders who purchased H-Quotient shares after February 22, 2005, and held them through April 22, 2005. Those dividend transfers will be handled by brokerage firms on April 27, 2005. The dividend is one share of Standard Holdings Group Ltd. (OTC: SNDH) common stock for each 10 shares of H-Quotient, Inc. This announcement may contain, in addition to histo... (more)

Medica Receives Highest Possible Accreditation Status for Commercial and Medicaid Plans From the Prestigious NCQA

MINNETONKA, MN -- (MARKET WIRE) -- 04/13/05 -- Medica has again been awarded the highest possible accreditation status, Excellent, by the prestigious National Committee for Quality Assurance (NCQA®) for its Minnesota Medicaid HMO and the commercial health plans it provides to Minnesotans, Wisconsinites, and North and South Dakotans. Medica's commercial health plans cover more than 1,027,000 individuals, while Medica's Medicaid HMO provides health coverage to more than 131,000 people. "This health plan is committed to continuous pursuit of the highest standards," said Dr. Charles ... (more)

Curative Health Services to Report First Quarter 2005 Results

NASHUA, NH -- (MARKET WIRE) -- 04/25/05 -- Curative Health Services, Inc. (NASDAQ: CURE) will hold a conference call to discuss the Company's first quarter 2005 financial results, recent developments, business strategy and outlook on Thursday, May 5, 2005, at 5:00 p.m. Eastern Time. To participate in the conference call via phone, dial 800-374-0191 approximately 10 minutes prior to the scheduled start time, or visit the Company's website at and select the Investor Relations link. A replay of the presentation will be available approximately two hours after the ev... (more)

Generex Biotechnology Signs Agreement With Cardinal Health for Generex Oral-lyn(TM) Manufacturing for Clinical Trials

TORONTO -- (MARKET WIRE) -- 06/22/06 -- Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that it has entered into contractual arrangements with Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health-care industry, to manufacture clinical trial batches of Generex Oral-lyn(TM), a proprietary oral insulin spray product. Under the terms of the contract, Cardinal Health will formulate and fill clinical trial batches of the canisters at its manufacturing and analytical servic... (more)

IBM Signs 10-Year Contract With AMB Generali

DÜSSELDORF, GERMANY -- (MARKET WIRE) -- 07/10/06 -- German insurance company AMB Generali and IBM today announced a 10-year agreement for IBM's business consultants to manage AMB's proprietary technology solution for the insurance industry. IBM will take over the servicing, maintenance and development of the AMB Generali Informatik Services (AMGIS) IP.Suite, a software tool for rating insurance products offered by the AMB Generali Group in Germany. AMB Generali is one of the largest primary insurance companies in Germany covering life, property and causality and health. The IP.... (more)